Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Asensus Surgical, Inc. ASXC NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+331.2%

Asensus Surgical, Inc. (ASXC) is a Medical - Devices company in the Healthcare sector, currently trading at $0.35. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Analyst consensus target is ASXC = $2 (+331.2% upside).

Financials: revenue is $9M, +55.5%/yr average growth. Net income is $78M (loss), growing at -10%/yr. Net profit margin is -914.5% (negative). Gross margin is -53.4% (+9.3 pp trend).

Balance sheet: total debt is $6M against $33M equity (Debt-to-Equity (D/E) ratio 0.17, conservative). Current ratio is 2.88 (strong liquidity). Debt-to-assets is 9.4%. Total assets: $61M.

Analyst outlook: 0 / 2 analysts rate ASXC as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 15/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$1.50
▲ 331.16% Upside
Average Price Target
The 12-month price target for Asensus Surgical, Inc. is $1.50.

ASXC SharesGrow Score Overview

56/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 15/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ASXC

✓
VALUE Pass
100/100
ASXC trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $2, implying +474.9% from the current price $0. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
ASXC: +55.5%/yr revenue is, -10%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet ASXC: Debt-to-Equity (D/E) ratio 0.17 (conservative), Current ratio is 2.88 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
15/100
ASXC: Gross margin is -53.4% (+9.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 15/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 0 / 2 analysts rate ASXC as buy (0%). Analyst consensus target is $2 (+474.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
ASXC: Net profit margin is -914.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.169-0.3993
Volume3.94M
Avg Volume (30D)3.26M
Market Cap$94.92M
Beta (1Y)1.38
Share Statistics
EPS (TTM)-0.31
Shares Outstanding$249.69M
IPO Date1991-08-06
Employees207
CEOAnthony Fernando
Financial Highlights & Ratios
Revenue (TTM)$8.58M
Gross Profit$-4.58M
EBITDA$-74.4M
Net Income$-78.43M
Operating Income$-79.47M
Total Cash$21.07M
Total Debt$5.68M
Net Debt$-11.41M
Total Assets$60.53M
Price / Earnings (P/E)-1.1
Price / Sales (P/S)11.07
Analyst Forecast
1Y Price Target$1.50
Target High$1.50
Target Low$1.50
Upside+331.2%
Rating ConsensusHold
Analysts Covering2
Buy 0% Hold 100% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS04367G1031

Price Chart

Track all markets on TradingView
ASXC
Asensus Surgical, Inc. ↗  ·  NYSE
Healthcare • Medical - Devices
0.17 52WK RANGE 0.40

People Also View

SENS
SENS
Senseonics Holdings, Inc.
$6.90
+2.22%
 FRSX
FRSX
Foresight Autonomous Holdings Ltd.
$2.48
+1.64%
 ADMP
ADMP
Adamis Pharmaceuticals Corporation
$0.78
+0.85%
 BNGO
BNGO
Bionano Genomics, Inc.
$1.28
+5.79%
 JAGX
JAGX
Jaguar Health, Inc.
$0.42
+4.19%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message